Network origin in Yan Rong Zhao first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Medical/Nursing Services | 12 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Yan Rong Zhao via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
VITRO DIAGNOSTICS, INC. | Chemicals: Major Diversified | Corporate Officer/Principal | |
Warwick Business School | College/University | Graduate Degree | |
The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
CHINA VANKE CO., LTD. | Real Estate Development | Director/Board Member | |
BYD COMPANY LIMITED | Electrical Products | Director/Board Member | |
National University of Singapore | College/University | Graduate Degree | |
CITIC Group Corp.
CITIC Group Corp. Finance/Rental/LeasingFinance CITIC Group Corp. provides financial services. It operates through the following business segments: Financial and Non-financial. The Financial segment includes banking, securities, trust, and insurance. The Non-financial segment includes resources and energy, manufacturing, engineering contracting, and real estate and infrastructure. The company was founded by Yi Ren Rong in October 1979 and is headquartered in Beijing, China. | Finance/Rental/Leasing | Corporate Officer/Principal | |
Peking University
Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
The University of Chicago | College/University | Doctorate Degree | |
The Johns Hopkins University | College/University | Corporate Officer/Principal Doctorate Degree | |
Kansas State University | College/University | Undergraduate Degree | |
University of Kansas | College/University | Doctorate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal | |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
University of Science & Technology of China | College/University | Undergraduate Degree | |
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
University of Science & Technology Beijing | College/University | Undergraduate Degree | |
Central University of Finance & Economics | College/University | Undergraduate Degree | |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Biotechnology | Corporate Officer/Principal | |
German Cancer Research Center
German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Hospital/Nursing Management | Director/Board Member | |
Sinolink Securities (Hong Kong) Co. Ltd.
Sinolink Securities (Hong Kong) Co. Ltd. Investment Banks/BrokersFinance Part of Sinolink Securities Co., Ltd., Sinolink Securities (Hong Kong) Co. Ltd. is a brokerage company based in Hong Kong, Hong Kong. The Chinese company provides brokerage services. The company was founded in 1987. The CEO is Yan Long Wang. | Investment Banks/Brokers | Chairman | |
China National Packaging Corp.
China National Packaging Corp. Industrial MachineryProducer Manufacturing China National Packaging Corp. provides packaging services and related products. The company is based in Beijing, China. The Chinese company is ultimately controlled by the Government of China. | Industrial Machinery | Corporate Officer/Principal | |
National Development & Reform Commission | General Government | Corporate Officer/Principal | |
Springridge Investment Management Ltd. | Chairman | ||
Chinese Academy of Medical Sciences | College/University | Corporate Officer/Principal | |
State Economic & Trade Commission | Corporate Officer/Principal | ||
Peking Union Medical College | College/University | Doctorate Degree | |
Peking University Health Science Center | College/University | Doctorate Degree | |
New China Asset Management Co., Ltd.
New China Asset Management Co., Ltd. Investment ManagersFinance New China Asset Management Co., Ltd. (NCAMC) is the asset management subsidiary of New China Life Insurance Co., Ltd. (SHA: 601336) in China. Founded in 2006, NCAMC is headquartered in Beijing and primarily provides investment services to institutional investors and insurance companies. | Investment Managers | Chairman | |
CICC Jiacheng Investment Management Co. Ltd.
CICC Jiacheng Investment Management Co. Ltd. Investment ManagersFinance CICC Jiacheng Investment Management Co. Ltd. (CICC Jiacheng Investment) is a private equity and venture capital subsidiary of China International Capital Corp. Ltd. founded in 2007. The firm is headquartered in Beijing, China. | Investment Managers | Director/Board Member | |
Beijing Genetron Biotechnology Co. Ltd.
Beijing Genetron Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Genetron Biotechnology Co. Ltd. provides healthcare solutions. It offers Cancer Genetic Testing, DNA Methylation Sequencing, RNA Sequencing, Whole-Exome Sequencing and Glioma Panel. The company was founded in December 2013 by Si-Zhen Wang and Hai Yan and is headquartered in Beijing, China. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
dMed Biopharmaceutical Technology (Shanghai) Co., Ltd.
dMed Biopharmaceutical Technology (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology DMed Biopharmaceutical Technology Shanghai Co., Ltd. engages in the development of medicines and medical devices. The company was founded by Ling Shi Tan on August 3, 2016 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
Duke Cancer Institute
Duke Cancer Institute Hospital/Nursing ManagementHealth Services Duke Cancer Institute is an organization that unites the academic and clinical communities of Duke University and the Duke University Health System. The non-profit company is based in Durham, NC and has subsidiaries in the United States. The company's main focus is to provide access to technologies, services, and scientific consultation through its Shared Resources. | Hospital/Nursing Management | Corporate Officer/Principal | |
Blackstone (Shanghai) Equity Invt Mgmt Co. Ltd.
Blackstone (Shanghai) Equity Invt Mgmt Co. Ltd. Investment ManagersFinance Part of Blackstone, Inc., Blackstone (Shanghai) Equity Invt Mgmt Co. Ltd. is a Chinese company that provides investment management services. The company is based in Shime Yi, China. | Investment Managers | Corporate Officer/Principal | |
Beijing Genetron Health Gene Technology Co., Ltd.
Beijing Genetron Health Gene Technology Co., Ltd. Information Technology ServicesTechnology Services Beijing Genetron Health Gene Technology Co. Ltd. provides software development services. It also engages in the import, export and sale of medical equipment. The company was founded on May 7, 2015 and is headquartered in Beijing, China. | Information Technology Services | Director/Board Member Chief Executive Officer Director/Board Member | |
INNOCARE PHARMA LIMITED | Pharmaceuticals: Major | Director/Board Member | |
NEW FRONTIER HEALTH CORPORATION | Packaged Software | Director/Board Member | |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Medical Specialties | Director/Board Member | |
Guangdong Capital Holdings Ltd. | Chief Executive Officer | ||
Guangdong Asia Insurance Co. Ltd. | Chairman | ||
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Pharmaceuticals: Major | Director/Board Member | |
MICROPORT CARDIOFLOW MEDTECH CORPORATION | Medical Specialties | Director/Board Member | |
LEPU SCIENTECH MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
Esco Lifesciences Group Ltd.
Esco Lifesciences Group Ltd. Miscellaneous Commercial ServicesCommercial Services Esco Lifesciences Group Ltd. is a multinational life sciences company, engages in the development, manufacture, and sale of life sciences, pharmaceutical and bioprocessing tools as well as the offering of related after-sales and support services. It operates through the following segments: Esco Scientific, Esco Medical, Esco Healthcare, and Esco Services. The Esco Scientific segment provides mission critical life sciences laboratory equipment such as biological safety cabinets, laminar flow clean benches, CO2 and CO2/O2 incubators, fume hoods, centrifuges and others used in research, clinical and industrial settings for preparation, cultivation, handling and analytical purposes. The Esco Medical segment manufactures and sells medical devices such as incubators, workstations, and consumables for IVF treatment. The Esco Healthcare segment provides pharmaceutical equipment and bioprocessing tools, primarily containment and isolation systems for the production of medicines, vaccines, and cell and gene therapies. The Esco Services segment offers after-sales and support services to customers of Esco Scientific, Esco Medical, and Esco Healthcare. The company was founded on February 1, 2021 and is headquartered in Singapore. | Miscellaneous Commercial Services | Director/Board Member | |
MICROPORT NEUROTECH LIMITED | Medical Specialties | Director/Board Member | |
Ludwig Cancer Research | Corporate Officer/Principal | ||
VISEN Pharmaceuticals
VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
Huazhong Agricultural University | College/University | Undergraduate Degree |
Statistics
International
China | 29 |
United States | 12 |
Hong Kong | 6 |
Cayman Islands | 3 |
United Kingdom | 2 |
Sectoral
Consumer Services | 18 |
Health Technology | 10 |
Finance | 9 |
Producer Manufacturing | 3 |
Government | 3 |
Operational
Director/Board Member | 35 |
Corporate Officer/Principal | 20 |
Chairman | 9 |
Undergraduate Degree | 9 |
Independent Dir/Board Member | 8 |
Most connected contacts
Insiders | |
---|---|
Dian Kang | 20 |
Shan Fu | 17 |
Wing Kee Lau | 13 |
Hai Yan | 8 |
Xia Wu | 7 |
Si Zhen Wang | 5 |
Webster Cavenee | 5 |
Yu Chen Jiao | 5 |
Chao Tang | 5 |
Yun Fu Hu | 5 |
Ce Xu | 2 |
Ying Hong | 1 |
- Stock Market
- Insiders
- Yan Rong Zhao
- Company connections